Expression and regulation of thioredoxin reductases and other selenoproteins in bone

Methods Enzymol. 2002:347:168-79. doi: 10.1016/s0076-6879(02)47015-2.

Abstract

The expression of thioredoxin reductases and other selenoproteins in cells of the bone microenvironment may represent an important means of regulation of bone resorption and remodeling in health and disease. Selenoproteins and their substrates may influence intracellular and extracellular redox-dependent signaling, transcription factor activity, posttranslational modification of proteins, and general or compartmentalized scavenging from ROIs. However, the evaluation of their biological role in bone and their potential in terms of therapeutic approaches is just beginning.

MeSH terms

  • Bone Diseases, Metabolic / drug therapy
  • Bone Diseases, Metabolic / metabolism
  • Bone and Bones / metabolism*
  • Calcitriol / pharmacology
  • Gene Expression Regulation, Enzymologic / drug effects
  • Glutathione Peroxidase / metabolism
  • Humans
  • In Vitro Techniques
  • Methods
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism
  • Osteoclasts / metabolism
  • Oxidation-Reduction
  • Proteins / genetics
  • Proteins / metabolism*
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Reactive Oxygen Species / metabolism
  • Selenium / deficiency
  • Selenium / therapeutic use
  • Selenoproteins
  • Thioredoxin-Disulfide Reductase / analysis
  • Thioredoxin-Disulfide Reductase / genetics
  • Thioredoxin-Disulfide Reductase / metabolism*

Substances

  • Proteins
  • RNA, Messenger
  • Reactive Oxygen Species
  • Selenoproteins
  • Glutathione Peroxidase
  • Thioredoxin-Disulfide Reductase
  • Calcitriol
  • Selenium